About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Tennessee | 991 Studies

Clinical Trials Breast CancerTennessee

Breast Cancer Clinical Trials in Tennessee

Find 991 clinical trials for breast cancer near Tennessee. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 361-380 of 991 trials

TerminatedNBE-002 in Patients With Advanced Solid TumorsThis first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and…NCT04441099·Nashville, Tennessee and 2 others CompletedS0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00075764·Anniston, Alabama and 425 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerThe treatment received with sunitinib plus capecitabine could delay tumor growth longer than with treatment with capecitabine alone.NCT00435409·Downey, California and 168 others

CompletedFeasibility Study of Meso BioMatrix Device for Breast ReconstructionThe purpose of the study is to evaluate the safety and feasibility of the use of Meso BioMatrix Acellular Peritoneum Matrix for the reinforcement of weakened soft tissue during…NCT01823107·Detroit, Michigan and 5 others

TerminatedLapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer SubjectsThis is an open-label, single-arm, multi-center, Phase II study to determine the activity of vinorelbine plus lapatinib in either first- or second-line setting in women with ErbB2…NCT00709618·Muscle Shoals, Alabama and 21 others

CompletedStudy of Pralatrexate in Female Patients With Previously-treated Breast CancerThe purpose of this study is to determine the efficacy (ability to provide a beneficial treatment of the disease) of pralatrexate for the treatment of female patients with…NCT01118624·Portland, Oregon and 13 others

TerminatedTesting the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerThis randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread…NCT03199885·Birmingham, Alabama and 672 others

TerminatedA Study of PY314 in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, first in human, Phase 1a/1b study of PY314 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are refractory…NCT04691375·Phoenix, Arizona and 22 others

CompletedInvestigation of Genetic Determinants of Capecitabine ToxicityThe purpose of this study is to identify possible genetic polymorphisms that contribute to specific toxicities associated with capecitabine (hand-foot syndrome, diarrhea, and…NCT00977119·Birmingham, Alabama and 12 others

CompletedTamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerThis randomized phase III trial studies tamoxifen citrate or letrozole together with bevacizumab to see how well it works compared with tamoxifen citrate or letrozole alone in…NCT00601900·Mobile, Alabama and 521 others

RecruitingPilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyThe purpose of this study is to determine if the radiotracer, \[68Ga\]Ga-ABY-025, used for PET imaging can help us better identify and visualize lesions or tumors, in patients who…NCT06828588·Nashville, Tennessee

CompletedE7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesThe purpose of this study is to compare E7389 versus capecitabine in patients with locally advanced or metastatic breast cancer who are refractory to the most recent chemotherapy.NCT00337103·Anaheim, California and 168 others

RecruitingDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.NCT06239194·Denver, Colorado and 5 others

CompletedPhase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast CancerThe purpose of the Phase 1b portion of the study is to determine the best dose of PLX3397 when given in combination with standard dose eribulin (Halaven™).NCT01596751·San Francisco, California and 2 others

TerminatedSafety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerThis Phase I/II study is designed to assess the safety and therapeutic effect of INCB007839 in combination with trastuzumab and vinorelbine in patients with metastatic HER2+…NCT01254136·Fayetteville, Arkansas and 13 others

CompletedAnalysis of Surgery in Patients Presenting With Stage IV Breast CancerThe purpose of this study is to study patients presenting with stage IV breast cancer.NCT00941759·Birmingham, Alabama and 19 others

Active not recruitingA Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsThis is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in…NCT04478279·San Francisco, California and 10 others

CompletedOral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.The purpose of this study is to determine the efficacy of an oral investigational drug for the treatment of metastatic breast cancer tumors that are known to overexpress HER2/neu.NCT00051103·Chula Vista, California and 29 others

CompletedBioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)Based upon the current state of science, the investigators are proposing to conduct a randomized clinical trial in which participants are randomized post-surgery to either BIS or…NCT02167659·Jacksonville, Florida and 9 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

PreviousPage 19 of 50Next

Other Conditions in Tennessee

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma